Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-1366-CM18 | 27-12-2018 | Acepta Com S.A. | Recepcion Conforme | $38.692 |
| 2980-1358-SE18 | 14-12-2018 | Novartis Chile S.A. | Recepcion Conforme | $3.172.049 |
| 2980-1359-SE18 | 14-12-2018 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $4.273.290 |
| 2980-1360-SE18 | 14-12-2018 | Productos Farmoquimicos Roche Limitada | Recepcion Conforme | $1.375.469 |
| 2980-1361-SE18 | 14-12-2018 | Novofarma Service S.A. | Recepcion Conforme | $2.498.719 |
| 2980-1362-SE18 | 14-12-2018 | Laboratorio Biotoscana Farma SpA | Recepcion Conforme | $1.074.813 |
| 2980-1363-SE18 | 14-12-2018 | Astrazeneca S.A. | Recepcion Conforme | $806.820 |
| 2980-1364-SE18 | 14-12-2018 | Tecnofarma S.A. | Recepcion Conforme | $1.691.533 |
| 2980-1348-SE18 | 12-12-2018 | Novartis Chile S.A. | Recepcion Conforme | $3.637.318 |
| 2980-1349-SE18 | 12-12-2018 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $4.273.290 |
| 2980-1350-SE18 | 12-12-2018 | Laboratorio Genzyme Chile Limitada | Recepcion Conforme | $2.155.716 |
| 2980-1353-SE18 | 12-12-2018 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $4.304.349 |
| 2980-1354-SE18 | 12-12-2018 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | Recepcion Conforme | $2.704.693 |
| 2980-1356-SE18 | 12-12-2018 | Astrazeneca S.A. | Recepcion Conforme | $1.549.023 |
| 2980-1357-SE18 | 12-12-2018 | Novartis Chile S.A. | Recepcion Conforme | $4.153.077 |
| 2980-1345-SE18 | 11-12-2018 | Sociedad de Nutricionistas Nutrihouse Limitada | Recepcion Conforme | $403.648 |
| 2980-1346-SE18 | 11-12-2018 | Novartis Chile S.A. | Recepcion Conforme | $1.275.494 |
| 2980-1347-CM18 | 11-12-2018 | Sociedad de Nutricionistas Nutrihouse Limitada | Recepcion Conforme | $516.000 |
| 2980-1319-CM18 | 06-12-2018 | Comunicacion Grafica e Impresores Ltda. | Recepcion Conforme | $5.363.680 |
| 2980-1338-SE18 | 06-12-2018 | Theoduloz y Cía. SpA | Recepcion Conforme | $437.899 |
| 2980-1339-SE18 | 06-12-2018 | Pfizer Chile S.A. | Recepcion Conforme | $3.062.807 |
| 2980-1344-SE18 | 06-12-2018 | Laboratorio Genzyme Chile Limitada | Recepcion Conforme | $718.572 |
| 2980-1305-SE18 | 05-12-2018 | Productos Farmoquimicos Roche Limitada | Recepcion Conforme | $595.690 |
| 2980-1296-SE18 | 04-12-2018 | Laboratorio Biotoscana Farma SpA | Recepcion Conforme | $797.414 |
| 2980-1297-SE18 | 04-12-2018 | Novartis Chile S.A. | Recepcion Conforme | $583.106 |
| 2980-1301-SE18 | 04-12-2018 | Abbott Laboratories de Chile Ltda. | Recepcion Conforme | $1.081.900 |
| 2980-1302-SE18 | 04-12-2018 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $1.434.783 |
| 2980-1303-SE18 | 04-12-2018 | Comercial Kendall (Chile) Ltda. | Recepcion Conforme | $436.942 |
| 2980-1304-SE18 | 04-12-2018 | Comercial General Biotec Chile SpA | Recepcion Conforme | $1.190.000 |
| 2980-1306-SE18 | 04-12-2018 | Laboratorio Biotoscana Farma SpA | Recepcion Conforme | $1.656.456 |
